Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2011. Start Trial.
Date Value
September 30, 2026 99.48%
August 31, 2026 99.48%
July 31, 2026 99.48%
June 30, 2026 99.48%
May 31, 2026 99.48%
April 30, 2026 99.48%
March 31, 2026 99.48%
February 28, 2026 99.48%
January 31, 2026 99.48%
December 31, 2025 99.48%
November 30, 2025 99.48%
October 31, 2025 99.48%
September 30, 2025 99.48%
August 31, 2025 99.48%
July 31, 2025 99.48%
June 30, 2025 99.48%
May 31, 2025 99.48%
April 30, 2025 99.48%
March 31, 2025 99.48%
February 28, 2025 99.48%
January 31, 2025 99.48%
December 31, 2024 99.48%
November 30, 2024 99.48%
October 31, 2024 99.48%
September 30, 2024 99.48%
Date Value
August 31, 2024 99.48%
July 31, 2024 99.48%
June 30, 2024 99.48%
May 31, 2024 99.48%
April 30, 2024 99.48%
March 31, 2024 99.48%
February 29, 2024 99.48%
January 31, 2024 99.48%
December 31, 2023 99.48%
November 30, 2023 99.48%
October 31, 2023 99.48%
September 30, 2023 99.41%
August 31, 2023 99.40%
July 31, 2023 99.40%
June 30, 2023 99.40%
May 31, 2023 99.40%
April 30, 2023 99.40%
March 31, 2023 99.40%
February 28, 2023 98.58%
January 31, 2023 98.15%
December 31, 2022 98.15%
November 30, 2022 98.15%
October 31, 2022 97.25%
September 30, 2022 96.76%
August 31, 2022 96.76%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Omeros Corp. 95.41%
Hyperion DeFi, Inc. 99.84%
ANI Pharmaceuticals, Inc. 72.96%
Corcept Therapeutics, Inc. 71.85%
Veru, Inc. 99.12%